Industry Overview

People

Lakeshore Biomaterials (Birmingham, AL, www.lakeshorebiomaterials.com) named two new executives to its staff. Joining Lakeshore are Paul Spencer as vice-president and general manager and John Middleton as chief scientific officer.   BioProcess Technology Consultants, Inc., (Acton, MA, www.bioprocessconsultants.com) has appointed Sheila G. Magil, PhD, as a consultant, focusing on product and method development, analytical technologies, and quality control.   AION Diagnostics Limited, a subsidiary of pSivida Limited (Perth WA, Australia, www.psivida.com.au), has appointed Jörg Schreiber, PhD, as a nonexecutive director.   Whatman PLC (Brentford, Middlesex, UK, www.whatman.com) has appointed Timothy J. Haines as chief executive, effective Sept. 1, 2005. For the past five years, Haines has served as chief executive of Astex Technology, a UK-based drug discovery and development company.   Merrimack Pharmaceuticals (Cambridge, MA, www.merrimackpharma.com) has elected Gary L. Crocker as chairman of its board of directors. Crocker was initially elected to the Merrimack board in 2004, when he participated in the company's $28 million Series C funding round. Jonca Bull, MD has joined the FDA Office of Pharmacoepidemiology and Statistical Science (OPaSS, www.fda.gov) as the deputy director. In this position, she will assume a key management role in the center and will be responsible for developing and implementing many of the drug safety and statistical strategic initiatives in OPaSS.   John M. Taylor, III, FDA's associate commissioner for regulatory affairs, announced his decision to leave FDA after a 14 year career at the agency. Margaret O'K. Glavin, FDA's current assistant commissioner in the Office of Counterterrorism Policy and Planning, has been named the new associate commissioner.   Alexander R. Giaquinto, PhD, has joined Tunnell Consulting (King of Prussia, PA, www.tunnellconsulting.com) as vice-president, and will serve as a senior adviser to the firm in the areas of regulatory strategy, research and development, clinical manufacturing, and regulatory affairs. The New Jersey High-Tech Hall of Fame (Trenton, NJ, www.njhightech.org) recently announced its 2005 inductees, including three leaders in the pharmaceutical industry, Geert Cauwenbergh, chairman and CEO of Barrier Therapeutics, Inc; Cecil B. Pickett, President of Schering-Plough Research Institute; and Martin Soeters, President of Novo Nordisk, Inc.   Airgas, Inc. (Randor, PA, www.airgas.com) named Michael Rohde to the new role of senior vice-president of distribution operations. Rohde will report directly to Mike Molinini, executive vice-president and chief operating officer, and head a new corporate department that will integrate several units providing operational support to the 13 regional companies within Airgas. James V. Blackwell, PhD, has joined BioProcess Technology Consultants (Acton, MA, www.bioprocessconsultants.com). Blackwell brings more than 13 years of experience in manufacturing, cell culture and fermentation technologies, biopharmaceutical development, and commercial operations technical support.   Protiveris Inc. (Rockville, MD, www.protiveris.com) has appointed Gregory Kellogg, PhD, as chief technology officer. Formerly vice-president of research at Network Biosytems, Kellogg managed the development of a microfabrication-based electrophoresis system for forensic applications. (continued to Calendar)